Return to Contents in this Issue |
Practitioner's Corner |
Safety of a 2-Visit Cluster Schedule
of Venom Immunotherapy in Outpatients at Risk of
Lifethreatening |
I Sánchez-Machín,1 C Moreno,2 R González,1 J Iglesias-Souto,1 E Pérez,1 V Matheu1,3,4 |
1Allergy Service, Hospital
Universitario NS Candelaria, Santa Cruz de Tenerife,
Spain |
J Investig Allergol Clin Immunol 2010; Vol. 20(1): 89-92 |
|